download.jpg
BIIB 4-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Biogen Inc. (BIIB) Investors with Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action
April 04, 2022 15:11 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Biogen Inc. (NASDAQ: BIIB) investors with significant losses to submit your losses now. A securities fraud class action has been...
download.jpg
BIIB 10-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Biogen Inc. (BIIB) Investors with Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Class Action
March 29, 2022 09:36 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 29, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Biogen Inc. (NASDAQ: BIIB) investors with significant losses to submit your losses now. A securities fraud class action has been...
download.jpg
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Biogen Inc. (BIIB) Investors with Losses to Contact Firm’s Attorneys, Securities Class Action Filed
February 22, 2022 09:33 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Biogen Inc. (NASDAQ: BIIB) investors with significant losses to submit your losses now.   A securities fraud class action has...
download.jpg
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Biogen Inc. (BIIB) Investors with Losses to Contact Firm’s Attorneys About Lead Plaintiff Opportunity in Securities Class Action
February 14, 2022 09:37 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Biogen Inc. (NASDAQ: BIIB) investors with significant losses to submit your losses now.   A securities fraud class action has...
download.jpg
HAGENS BERMAN BIIB ALERT: Investors in Biogen Inc. (BIIB) With Significant Losses Have Opportunity to Lead Securities Class Action
February 08, 2022 20:11 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Biogen Inc. (NASDAQ: BIIB) investors with significant losses to submit your losses now. A securities fraud class action has been...